Socrus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 10-12-2024
- Paid Up Capital ₹ 8.18 Cr
as on 10-12-2024
- Company Age 38 Year, 10 Months
- Last Filing with ROC 31 Mar 2012
- Open Charges ₹ 17.33 Cr
as on 10-12-2024
- Satisfied Charges ₹ 7.65 M
as on 10-12-2024
About Socrus Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2012. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 8.18 Cr.
The company currently has active open charges totaling ₹17.33 Cr. The company has closed loans amounting to ₹7.65 M, as per Ministry of Corporate Affairs (MCA) records.
Madhvi Agnihotri, Rajeev Agnihotri, Rajshree Trivedi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232MP1986PLC003300
- Company No.
003300
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
13 Feb 1986
- Date of AGM
29 Sep 2012
- Date of Balance Sheet
31 Mar 2012
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Dhar, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Socrus Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Agnihotri  | Managing Director | 27-Jan-1996 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhvi Agnihotri | Director | 10-Jun-1995 | Current |
| Rajshree Trivedi | Director | 05-Jun-1990 | Current |
| Sanjay Upadhyay | Additional Director | 30-Jan-2012 | Current |
Financial Performance and Corporate Structure Insights of Socrus Pharmaceuticals.
Enhance accessibility to Socrus Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Socrus Pharmaceuticals?
Unlock access to Socrus Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Socrus Bio Sciences LimitedActive 35 years 1 monthMadhvi Agnihotri, Rajeev Agnihotri and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Panjab National Bank Creation Date: 22 Aug 2006 | ₹5.75 Cr | Open |
Asset Reconstruction Company (India) Limited Creation Date: 27 Dec 2004 | ₹1.50 M | Open |
Asset Reconstruction Company (India) Limited Creation Date: 22 Nov 2004 | ₹10.25 Cr | Open |
How Many Employees Work at Socrus Pharmaceuticals?
Unlock and access historical data on people associated with Socrus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Socrus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Socrus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
